Modern concepts of kidney damage in patients with systemic scleroderma

Abdullaeva Umida Kurbanovna, Nabieva Dildora Abdumalikovna, Yusupov Ilkhom Kobulzhonovich

dc.contributor.author	Abdullaeva Umida Kurbanovna, Nabieva Dildora Abdumalikovna, Yusupov Ilkhom Kobulzhonovich
dc.date.accessioned	2024-01-15T01:37:22Z
dc.date.available	2024-01-15T01:37:22Z
dc.date.issued	2023-08
dc.identifier.issn	2181-712Х
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/10060
dc.description.abstract	Systemic sclerosis, or systemic scleroderma (SSD), is an autoimmune disease of connective tissue, the main clinical signs of which are caused by widespread microcirculation disorders, fibrosis of the skin and internal organs. According to morphological studies, 80% of patients with SSD have kidney changes, including those not associated with rheumatic diseases. While the prevalence of sclerodermic renal crisis is currently estimated at 2-5%, an asymptomatic decrease in renal function ("mute uremia") due to the presence of multimorbid and comorbid pathology is much more often noted. Its frequency in patients with SSD can reach 55%.	en_US
dc.language.iso	other	en_US
dc.publisher	Тиббиётда янги кун	en_US
dc.subject	systemic scleroderma; sclerodermic renal crisis; vascular endothelial dysfunction; chronic sclerodermic nephropathy; nonimmune factors of nephropathy progression; chronic kidney disease.	en_US
dc.title	Modern concepts of kidney damage in patients with systemic scleroderma	en_US
dc.type	Article	en_US